Swedish start-up Pilloxa has initiated a strategic partnership with Bayer AB for an innovative smart pillbox to tackle the ever-growing problem of patient compliance.
Bayer AG and its cooperation partner Janssen Research & Development, LLC have announced that the Phase III trial COMPASS evaluating the efficacy and safety of rivaroxaban (Xarelto®) for the prevention of major adverse cardiac events (MACE)...